Drugs / PRG2302
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06659653 | May 2024 → Mar 2027 expected | acute lymphoblastic leukemia | Tan Jie | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRG2302 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06659653 ↗ |